Clinician's Choice Cardio Guardian
Clinician's Choice Cardio Guardian, NPN 80078930: natural health product licensed in Canada. Medicinal ingredients: Acide L-ascorbique, Vitamine B6, Folate, Vitamine B12.
If this product were sold in France
- Declared dose above a limit
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide L-ascorbique Source : Acide ascorbique | 250 milligramme | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 2.5 milligramme | 10,000 µg |
| Folate Source : Acide folique | 100 microgrammes | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 100 microgrammes | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 25 milligramme | Not calculated |
| Vitis vinifera Source : Vitis vinifera - Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 62.5 milligramme Potency : 30 % Polyphenols | 12.5 milligramme | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 500 microgrammes | Not calculated |
| Oryza sativa fermenté avec Monascus purpurea Source : Monascus pilosus - Whole | 250 milligramme | Not calculated |
| L-Carnitine Source : L-tartrate de carnitine | 250 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropyl méthylcellulose, Huile essentielle de verveine des Indes orientale, Acide stéarique, Cire de Carnauba, Dioxyde de silicium, Croscarmellose de sodium, Phosphate dicalcique, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 2 days |
Uses authorised in Canada
Source of antioxidants for the maintenance of good health. Helps to maintain and support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications. If you have a liver disease, a kidney disease, or a seizure disorder, consult a healthcare practitioner prior to use. Consult a health care practitioner prior to use if you are taking blood pressure medication. Consult a health care practitioner prior to use if you are taking blood thinners.
Product record
- Licence holder
- Vamako Pharmaceuticals Inc.
- NPN or DIN-HM
- 80078930
- Status
- Active licence
- Licence date
- 7 July 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80078930
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- L-Carnitine
Read the warning, when it applies and the studies cited
L-CARNITINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Clinician's Choice Cardio Guardian (Vamako Pharmaceuticals Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80078930-clinician-s-choice-cardio-guardian, updated 7 July 2017.